UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

EZH2 is essential for glioblastoma cancer stem cell maintenance

Cancer research (Chicago, Ill.), 2009-12, Vol.69 (24), p.9211-9218

2009

Volltextzugriff (PDF)

Long-term follow-up for childhood cancer survivors: the Geneva experience

Swiss medical weekly, 2022-03, Vol.152 (1314), p.w30153

2022

Volltextzugriff (PDF)

Limits of CD133 as a marker of glioma self‐renewing cells

International journal of cancer, 2009-07, Vol.125 (1), p.244-248

2009

Volltextzugriff (PDF)

Predictors for participation in DNA self-sampling of childhood cancer survivors in Switzerland

BMC medical research methodology, 2021-10, Vol.21 (1), p.1-236, Article 236

2021

Volltextzugriff (PDF)

Therapeutic Drug Monitoring of Busulfan for the Management of Pediatric Patients: Cross-Validation of Methods and Long-Term Performance

Therapeutic drug monitoring, 2018-02, Vol.40 (1), p.84-92

2018

Volltextzugriff (PDF)

Cohort-based association study of germline genetic variants with acute and chronic health complications of childhood cancer and its treatment: Genetic Risks for Childhood Cancer Complications Switzerland (GECCOS) study protocol

BMJ open, 2022-01, Vol.12 (1), p.e052131-e052131

2022

Volltextzugriff (PDF)

PRIMA-1MET-induced neuroblastoma cell death is modulated by p53 and mycn through glutathione level

Journal of experimental & clinical cancer research, 2019-02, Vol.38 (1), p.69-69, Article 69

2019

Volltextzugriff (PDF)

The Association of Combined GSTM1 and CYP2C9 Genotype Status with the Occurrence of Hemorrhagic Cystitis in Pediatric Patients Receiving Myeloablative Conditioning Regimen Prior to Allogeneic Hematopoietic Stem Cell Transplantation

Frontiers in pharmacology, 2017-07, Vol.8, p.451-451

2017

Volltextzugriff (PDF)

Urinary α1-Antichymotrypsin: A Biomarker of Prion Infection

PloS one, 2008-12, Vol.3 (12), p.e3870

2008

Volltextzugriff (PDF)

Experimental autoimmune encephalomyelitis repressed by microglial paralysis

Nature medicine, 2005-02, Vol.11 (2), p.146-152

2005

Volltextzugriff (PDF)

Marker-independent identification of glioma-initiating cells

Nature methods, 2010-03, Vol.7 (3), p.224

2010

Volltextzugriff (PDF)

In vivo brain macromolecule signals in healthy and glioblastoma mouse models: 1 H magnetic resonance spectroscopy, post‐processing and metabolite quantification at 14.1 T

Journal of neurochemistry, 2014-06, Vol.129 (5), p.806-815

2014

Volltextzugriff (PDF)

In vivo metabolic profiling of glioma-initiating cells using proton magnetic resonance spectroscopy at 14.1 Tesla

NMR in biomedicine, 2012-04, Vol.25 (4), p.506-513

2012

Volltextzugriff (PDF)

In vivo brain macromolecule signals in healthy and glioblastoma mouse models: 1H magnetic resonance spectroscopy, post‐processing and metabolite quantification at 14.1 T

Journal of neurochemistry, 2014-06, Vol.129 (5), p.806-815

2014

Volltextzugriff (PDF)

Ataxia-telangiectasia mutated (ATM) silencing promotes neuroblastoma progression through a MYCN independent mechanism

Oncotarget, 2015-07, Vol.6 (21), p.18558-18576

2015

Volltextzugriff (PDF)

PRIMA-1 MET -induced neuroblastoma cell death is modulated by p53 and mycn through glutathione level

Journal of experimental & clinical cancer research, 2019-02, Vol.38 (1), p.69

2019

Volltextzugriff (PDF)

Retraction Note: Marker-independent identification of glioma-initiating cells

Nature methods, 2013-09, Vol.10 (10), p.1035-1035

2013

Volltextzugriff (PDF)

Urinary alpha1-antichymotrypsin: a biomarker of prion infection

PloS one, 2008, Vol.3 (12), p.e3870-e3870

2008

Volltextzugriff (PDF)

Quantification, self-renewal, and genetic tracing of FL1+ tumor-initiating cells in a large cohort of human gliomas

Neuro-oncology (Charlottesville, Va.), 2014-06, Vol.16 (6), p.889-889

2014

Volltextzugriff (PDF)

Quantification, self-renewal, and genetic tracing of FL1⁺ tumor-initiating cells in a large cohort of human gliomas

Neuro-oncology (Charlottesville, Va.), 2012-06, Vol.14 (6), p.720-735

2012

Volltextzugriff (PDF)

Retracted: Marker-independent identification of glioma-initiating cells

Nature methods, 2010-02, Vol.7 (3), p.224-228

2010

Volltextzugriff (PDF)

88: An innovation for developing and validating niche-buster drugs

Bulletin du cancer, 2010-03, Vol.97 (1), p.S72-S73

2010

Volltextzugriff (PDF)

Urinary [alpha].sub.1-Antichymotrypsin: A Biomarker of Prion Infection

PloS one, 2008-12, Vol.3 (12), p.e3870

2008

Volltextzugriff (PDF)

Urinary alpha sub(1)-Antichymotrypsin: A Biomarker of Prion Infection

PloS one, 2008-01, Vol.3 (12), p.e3870-e3870

2008

Volltextzugriff (PDF)

Mechanical compartmentalization of the intestinal organoid enables crypt folding and collective cell migration

Nature cell biology, 2021-07, Vol.23 (7), p.745-757

2021

Volltextzugriff (PDF)

1 – 25 von 99

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(88)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

EZH2 is essential for glioblastoma cancer stem cell maintenance

Long-term follow-up for childhood cancer survivors: the Geneva experience

Limits of CD133 as a marker of glioma self‐renewing cells

Predictors for participation in DNA self-sampling of childhood cancer survivors in Switzerland

Therapeutic Drug Monitoring of Busulfan for the Management of Pediatric Patients: Cross-Validation of Methods and Long-Term Performance

Cohort-based association study of germline genetic variants with acute and chronic health complications of childhood cancer and its treatment: Genetic Risks for Childhood Cancer Complications Switzerland (GECCOS) study protocol

PRIMA-1MET-induced neuroblastoma cell death is modulated by p53 and mycn through glutathione level

The Association of Combined GSTM1 and CYP2C9 Genotype Status with the Occurrence of Hemorrhagic Cystitis in Pediatric Patients Receiving Myeloablative Conditioning Regimen Prior to Allogeneic Hematopoietic Stem Cell Transplantation

Urinary α1-Antichymotrypsin: A Biomarker of Prion Infection

Experimental autoimmune encephalomyelitis repressed by microglial paralysis

Marker-independent identification of glioma-initiating cells

In vivo brain macromolecule signals in healthy and glioblastoma mouse models: 1 H magnetic resonance spectroscopy, post‐processing and metabolite quantification at 14.1 T

In vivo metabolic profiling of glioma-initiating cells using proton magnetic resonance spectroscopy at 14.1 Tesla

In vivo brain macromolecule signals in healthy and glioblastoma mouse models: 1H magnetic resonance spectroscopy, post‐processing and metabolite quantification at 14.1 T

Ataxia-telangiectasia mutated (ATM) silencing promotes neuroblastoma progression through a MYCN independent mechanism

PRIMA-1 MET -induced neuroblastoma cell death is modulated by p53 and mycn through glutathione level

Retraction Note: Marker-independent identification of glioma-initiating cells

Urinary alpha1-antichymotrypsin: a biomarker of prion infection

Quantification, self-renewal, and genetic tracing of FL1+ tumor-initiating cells in a large cohort of human gliomas

Quantification, self-renewal, and genetic tracing of FL1⁺ tumor-initiating cells in a large cohort of human gliomas

Retracted: Marker-independent identification of glioma-initiating cells

88: An innovation for developing and validating niche-buster drugs

Urinary [alpha].sub.1-Antichymotrypsin: A Biomarker of Prion Infection

Urinary alpha sub(1)-Antichymotrypsin: A Biomarker of Prion Infection

Mechanical compartmentalization of the intestinal organoid enables crypt folding and collective cell migration

Suchergebnisse filtern